Sometimes, the conscious act of decision-making in humans is dramatically interrupted by situations that warrant an immediate response (e.g. when there is an imminent risk). The human body somatizes this interruption such that an action could be taken without a rational analysis. The above is known as a somatic marker. According to the somatic marker hypothesis, somatic markers could directly influence several ambits of decision-making. This research work presents the incorporation of artificial somatic reactions into affective autonomous agents who implement decision-making in the stock market. This implies the design of a general decision architecture for stock markets considering artificial somatic reactions and the definition of a set of decision-making algorithms for supporting investment decisions performed by affective autonomous agents (considering artificial somatic reactions). Test scenarios were defined using official data from Standard & Poor's 500 and Dow Jones. The experimental results are promising and indicated that affective autonomous agents are able to experience artificial somatic reactions and achieve effectiveness and efficiency in their decision-making.

有时，需要立即做出反应的情况（例如，迫在眉睫的风险）会极大地干扰人的决策意识。人体将这种中断躯体化，这样就可以在没有理性分析的情况下采取行动。以上被称为体细胞标记。根据体细胞标记假说，体细胞标记可以直接影响决策的几个方面。这项研究工作介绍了将人工躯体反应纳入在股票市场中实施决策的情感自主代理。这意味着考虑人工躯体反应的股票市场一般决策架构的设计，以及支持情感自主代理（考虑人工躯体反应）执行的投资决策的一组决策算法的定义。测试场景是使用标准普尔 500 指数和道琼斯指数的官方数据定义的。实验结果是有希望的，并表明情感自主主体能够经历人为的躯体反应并在其决策中达到有效性和效率。